Clinical Trial

Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial

Study acronym: ANGLE
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The Hyperangulated versus Standard Geometry Laryngoscope Blade (ANGLE) Trial is a multi-center, non-blinded, parallel-group, randomized clinical trial evaluating the effect of use of a hyperangulated video laryngoscope blade versus use of a standard geometry video laryngoscope blade. Critically ill adults undergoing tracheal intubation in participating EDs and ICUs who meet eligibility criteria will be enrolled and randomly assigned in a 1:1 ratio to either intubation using a hyperangulated video laryngoscope blade or a standard geometry video laryngoscope blade. The primary outcome is the incidence of successful intubation on the first attempt. The secondary outcome is incidence of hypoxemia during the interval between induction and 2 minutes after tracheal intubation.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-10-30; most recent amendment 2026-07-07.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-02
Trial Details
NCT Number NCT07223762
Lead Sponsor Vanderbilt University Medical Center
Conditions Acute Respiratory Failure
Enrollment 2,500 participants
Start Date 2025-12-30
Primary Completion 2027-04 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-09